P53(wt-p53) (D2F7) Monoclonal Antibody, PE-Cy7 Conjugated
Cat# bsm-2346M-PE-Cy7
Size : 100ul
Marca : Bioss
P53(wt-p53) (D2F7) Monoclonal Antibody, PE-Cy7 Conjugated
Applications
Reactivity
Overview | |
Catalog # | bsm-2346M-PE-Cy7 |
Product Name | P53(wt-p53) (D2F7) Monoclonal Antibody, PE-Cy7 Conjugated |
Applications | WB |
Reactivity | Human, Mouse, Rat |
Specifications | |
Conjugation | PE-Cy7 |
Host | Mouse |
Source | KLH conjugated synthetic peptide derived from human P53(wt-p53) |
Immunogen Range | 341-393/393 |
Clonality | Monoclonal |
Clone # | D2F7 |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein G. |
Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target | |
Gene ID | 7157 |
Synonyms | Widespread p53; Wtp53; Antigen NY-CO-13; Cellular tumor antigen p53; Cys 51 Stop; HGNC11998; LFS1; p53; p53 Cellular Tumor Antigen; p53 Tumor Suppressor; Phosphoprotein p53; TP53; Transformation related protein 53; TRP53; Tumor protein p53; Tumour Protein p53; P53_HUMAN; TP53. |
Background | This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons (PMIDs: 12032546, 20937277). [provided by RefSeq, Feb 2013]. |
Application Dilution | |
WB | 1:300-5000 |